glp-1 news november 2025 Receptor Agonist Market Growth Analysis Harvard Medical School Researcher Wins

This was based on some of her conversations with obese patients

Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market Trends and Insights Drivers Impact Analysis * Rising T2D And Obesity Prevalence Fuels Baseline Demand Adult diabetes cases in South and Central America climbed from 32 million in 2021 to 35.4 million in 2024 and are projected to reach 51.5 million by 2050, creating a vast patient pool for the Latin America GLP-1 agonists market

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health

Skovgaard M, et al

The glucagon pathway is one part of a wider mechanism involving appetite, fullness, insulin response and energy balance

Regional Outlook Across Key Markets The market analysis covers key global regions, including South Asia and Pacific, Middle East & Africa, North America, Latin America, Western Europe, and Eastern Europe